This Alere ordeal has put an uncomfortable spotlight on Abbott's M&A strategy, and the company still has to prove this pursuit was worthwhile.
from nicholemhearn digest http://www.chicagobusiness.com/article/20170929/NEWS03/170929846/abbott-labs-torturous-deal-saga-isnt-over-yet?utm_source=NEWS03&utm_medium=rss&utm_campaign=chicagobusiness
No comments:
Post a Comment